Drug Approvals
Invest in AbbVie? I've Made My Decision
The dividend in ABBV is key to making any investment decision regarding the stock.
Is Moderna's Bumpy Ride Lower Over for Now?
The stock is trading higher Monday on full approval for its Covid vaccine.
BioMarin Pharmaceutical Is Ready to Start a Fresh Advance
Here's where aggressive traders could go long BMRN.
I Don't Love Biogen, But Here's How to Trade It
I'm not saying get married to the stock, I'm saying that the idea could be a trade based on two possible catalysts.
Buying Moderna Now Could Be Akin to Trying to Catch a Falling Knife
Here's what traders can do.
Pfizer Is a Low-Beat, Dividend Stock: Here's What Patient Investors Can Do
Pfizer attributed the quarter's sales of Comirnaty, the firm's Covid-19 Messenger RNA vaccine, for the size of the top and bottom line beats.
2 Promising Small Biotechs in a Year That Has Been Tough on Most Little Guys
There are reasons to believe the shares of Dynavax Technologies and Eyenovia Inc. could do well in the months ahead.
What a Week, China's Troubles, Hypersonic Weapons, Earnings, FDA Drug Approvals
The lack of urgency at the FDA, as it is in the defense space, is alarming.
Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up
A recent trio of acquisition deals indicates the doldrums in the sector may be over.
Merck Continues to Reward Buyers
Investors are using the available weakness to buy the stock.